International Conference on Medicinal & Pharmaceutical Sciences
ICMPS
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest advancements in pharmaceutical chemistry, emphasizing novel drug design and synthesis methodologies. Participants will explore the integration of computational techniques in the development of new therapeutic agents.
SDG 3
SDG 9
This session will highlight the role of biotechnology in the discovery and development of new drugs. Discussions will cover biopharmaceuticals, gene therapy, and the application of biotechnological tools in enhancing drug efficacy.
SDG 3
SDG 9
This track addresses the ethical implications surrounding medical research and clinical trials. It aims to foster dialogue on informed consent, patient rights, and the responsibilities of researchers in safeguarding participant welfare.
SDG 3
SDG 16
This session will delve into cutting-edge biotechnological applications in medicine, including diagnostics, therapeutics, and regenerative medicine. Participants will examine case studies showcasing successful biotechnological interventions.
SDG 3
SDG 9
This track will explore the intersection of pharmacogenomics and personalized medicine, focusing on how genetic variations influence drug response. Discussions will include the implications for tailored therapies and improved patient outcomes.
SDG 3
SDG 9
This session will investigate the role of natural products as sources of new pharmaceuticals. Participants will discuss methodologies for isolating bioactive compounds and their potential therapeutic applications.
SDG 3
SDG 15
This track will address the regulatory landscape governing pharmaceutical development and approval processes. Experts will discuss challenges faced by researchers and companies in navigating compliance and ensuring drug safety.
SDG 3
SDG 16
This session will focus on the application of nanotechnology in medical sciences, particularly in drug delivery systems and diagnostics. Participants will explore the potential of nanomaterials to enhance therapeutic efficacy and reduce side effects.
SDG 3
SDG 9
This track will examine the evolving role of pharmacists in patient care and medication management. Discussions will include collaborative practices, patient counseling, and the impact of pharmacy services on health outcomes.
SDG 3
SDG 10
This session will explore contemporary issues in medical ethics, including end-of-life care, resource allocation, and the impact of technology on ethical decision-making. Participants will engage in critical discussions on ethical frameworks in healthcare.
SDG 3
SDG 16
This track will focus on integrative approaches that combine various disciplines within health and life sciences. Participants will discuss interdisciplinary strategies to address complex health challenges and improve patient care.
SDG 3
SDG 10